Literature DB >> 2632441

A family with adrenoleucodystrophy.

R P Singh, S Deshpande, R K Marwaha, K Garg.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2632441     DOI： 10.1007/bf02722392

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  14 in total

1.  Adrenoleukodystrophy. Preliminary report of a connatal case. Light- and electron microscopical, immunohistochemical and biochemical findings.

Authors:  J Ulrich; N Herschkowitz; P Heitz; T Sigrist; P Baerlocher
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

2.  Adrenoleukodystrophy and variants. Clinical, neurophysiological and biochemical studies in patients and family members.

Authors:  I Goto; T Kobayashi; Y Antoku; S Tobimatsu; Y Kuroiwa
Journal:  J Neurol Sci       Date:  1986-01       Impact factor: 3.181

3.  Detection of adrenoleucodystrophy carriers by means of evoked potentials.

Authors:  J B Moloney; J G Masterson
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

4.  Bone marrow transplant in adrenoleukodystrophy.

Authors:  H W Moser; P J Tutschka; F R Brown; A E Moser; A M Yeager; I Singh; S A Mark; A A Kumar; J M McDonnell; C L White
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910

5.  Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.

Authors:  H W Moser; A B Moser; N Kawamura; J Murphy; K Suzuki; H Schaumburg; Y Kishimoto
Journal:  Ann Neurol       Date:  1980-06       Impact factor: 10.422

6.  Identification of female carriers of adrenoleukodystrophy.

Authors:  H W Moser; A E Moser; J E Trojak; S W Supplee
Journal:  J Pediatr       Date:  1983-07       Impact factor: 4.406

7.  Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.

Authors:  H W Moser; A E Moser; I Singh; B P O'Neill
Journal:  Ann Neurol       Date:  1984-12       Impact factor: 10.422

8.  Abnormality of long-chain fatty acids in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy.

Authors:  S Tsuji; M Suzuki; T Ariga; M Sekine; M Kuriyama; T Miyatake
Journal:  J Neurochem       Date:  1981-03       Impact factor: 5.372

9.  Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.

Authors:  H W Moser; A B Moser; K K Frayer; W Chen; J D Schulman; B P O'Neill; Y Kishimoto
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910

10.  Magnetic resonance imaging compared with computed tomography in adrenoleukodystrophy.

Authors:  M S Huckman; P W Wong; T Sullivan; P Zeller; G K Geremia
Journal:  Am J Dis Child       Date:  1986-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.